Jazz Pharmaceuticals to Participate in Upcoming April Investor Conferences

Rhea-AI Summary

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is set to participate in key investor conferences in April 2022. The first event is the J.P. Morgan 11th Annual Napa Valley Biotech Forum on April 5, where management will engage in a fireside chat at 12:00 p.m. ET. The second event is the Needham Virtual Annual Healthcare Conference on April 11, featuring a panel on Future Treatment Trends in Epilepsy at 11:45 a.m. ET. Jazz is dedicated to developing innovative therapies in neuroscience and oncology, serving patients in nearly 75 countries.

DUBLIN, March 29, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following upcoming investor conferences:

J.P. Morgan 11^th Annual Napa Valley Biotech Forum

• Date: Tuesday, April 5, 2022
• Location: San Francisco
• Company management will participate in a fireside chat at 12:00 p.m. ET / 5:00 p.m. IST

Needham Virtual Annual Healthcare Conference

• Date: Monday, April 11, 2022
• Location: Virtual
• Company management will participate in the Future Treatment Trends in Epilepsy panel at 11:45 a.m. ET / 4:45 p.m. IST

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-april-investor-conferences-301513130.html

SOURCE Jazz Pharmaceuticals plc

FAQ

What investor conferences will Jazz Pharmaceuticals attend in April 2022?

Jazz Pharmaceuticals will attend the J.P. Morgan 11th Annual Napa Valley Biotech Forum on April 5, 2022, and the Needham Virtual Annual Healthcare Conference on April 11, 2022.

When is the J.P. Morgan Biotech Forum that Jazz Pharmaceuticals is participating in?

The J.P. Morgan 11th Annual Napa Valley Biotech Forum is scheduled for April 5, 2022.

What time will Jazz Pharmaceuticals' fireside chat take place at the J.P. Morgan Biotech Forum?

The fireside chat for Jazz Pharmaceuticals at the J.P. Morgan Biotech Forum will occur at 12:00 p.m. ET.

What panel will Jazz Pharmaceuticals be part of at the Needham Conference?

Jazz Pharmaceuticals will participate in the Future Treatment Trends in Epilepsy panel at the Needham Virtual Annual Healthcare Conference.

What is the date and time for Jazz Pharmaceuticals' panel discussion at the Needham Conference?

The panel discussion at the Needham Conference will take place on April 11, 2022, at 11:45 a.m. ET.